Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

NewAmsterdam’s CETP inhibitor obicetrapib shows promise in Alzheimer’s sub-study

The trial was primarily designed to assess the LDL-C lowering efficacy of the candidate

- PMLiVE

Galderma shares positive two-year results for Nemluvio in atopic dermatitis

The chronic inflammatory skin disease affects more than 230 million people worldwide

- PMLiVE

Darwin’s dictum on data

Take a view about what you see and then ask how well your view stands up against everything else you see

- PMLiVE

Merck’s RSV monoclonal antibody Enflonsia approved by FDA to protect infants

Enflonsia is now the first RSV preventive for infants that can be given at the same dose regardless of weight

- PMLiVE

Alnylam’s Amvuttra granted EC approval to treat rare heart disease ATTR-CM

The RNAi therapeutic has been authorised to treat both wild type and hereditary forms of the disease

- PMLiVE

Sobi/Apellis’ pegcetacoplan shows sustained efficacy in phase 3 kidney disease study

C3G and primary IC-MPGN are estimated to affect 5,000 people in the US and up to 8,000 in Europe

- PMLiVE

PM Society and the Chartered Institute of Marketing announce partnership

The alliance will centre around a series of face-to-face development training days in October

- PMLiVE

Shaping the future of cancer care

Advancing immunotherapies, ADCs and combination approaches

- PMLiVE

Sustainability and Environmental Impact in Market Access and Health Economics

As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and communicated across the Pharmaceutical and Medtech industries. In this article, experts...

Petauri Evidence

- PMLiVE

Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

Medscape Education

- PMLiVE

MHRA approves SFL’s Aumseqa to treat EGFR-mutated lung cancer in adults

Approximately 43,000 people are diagnosed with lung cancer every year in the UK

- PMLiVE

Otsuka shares promising phase 3 results for sibeprenlimab in rare kidney disease IgAN

The trial will continue to evaluate change in kidney function over two years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links